Anand Sampath's Insider Trades & SAST Disclosures
Anand Sampath's most recent trade in Masimo Corp was a trade of 2,637 Non-Qualified Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 26, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Anand Sampath.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 2,637 | 2,637 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 14,593 | 29,589 (0%) | 0% | 0 | Common Stock | |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2021 | 2,000 | 15,782 (0%) | 0% | 0 | Common Stock | |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2021 | 2,000 | 2,000 | - | - | Restricted Stock Units | |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 268.38 per share. | 02 Jan 2021 | 786 | 14,996 (0%) | 0% | 268.4 | 210,947 | Common Stock |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.77 per share. | 15 Dec 2020 | 15,000 | 28,782 (0%) | 0% | 21.8 | 326,550 | Common Stock |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 15,000 | 15,204 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.01 per share. | 15 Dec 2020 | 15,000 | 28,782 (0%) | 0% | 31.0 | 465,150 | Common Stock |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Sale of securities on an exchange or to another person at price $ 265.61 per share. | 15 Dec 2020 | 15,000 | 13,782 (0%) | 0% | 265.6 | 3,984,155 | Common Stock |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 15,000 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Sale of securities on an exchange or to another person at price $ 265.58 per share. | 15 Dec 2020 | 15,000 | 13,782 (0%) | 0% | 265.6 | 3,983,651 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges